Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Completed

• Conditions: Healthy

• Registration Number: NCT00314522
• Lead Sponsor: AHS Cancer Control Alberta

Brief Summary

This study performed a retrospective analysis of patient images to develop software in determining dose delivered for each fraction treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09
• Study Completion: 2006-03
• Study First Submitted: 2006-04-11
• Study First Submitted QC: 2006-04-13
• Study First Posted: 2006-04-14
• Status Verified: 2011-12
• Last Update Submitted: 2016-02-23
• Last Update Posted: 2016-02-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 5

Inclusion Criteria

• Subject 18 years of age and over

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Cross Cancer Institute; 🇨🇦 Edmonton, Alberta, Canada